6705-34-6

Basic information

• Product Name: 2-PYRAZINEPROPANOIC ACID
• Synonyms: 2-PYRAZINEPROPANOIC ACID;3-Pyrazin-2-yl-propionic acid;3-pyrazin-2-ylpropanoic acid(SALTDATA: FREE);3-pyrazin-2-ylpropanoic acid;3-(2-pyrazinyl)propanoic acid
• CAS NO: 6705-34-6
• Molecular Formula: C7H8N2O2
• Molecular Weight: 152.15
• Mol File: 6705-34-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 304.8°C at 760 mmHg
• Flash Point: 138.2°C
• Appearance: /
• Density: 1.269g/cm³
• Vapor Pressure: 0.000373mmHg at 25°C
• Refractive Index: 1.55
• CAS DataBase Reference: 2-PYRAZINEPROPANOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PYRAZINEPROPANOIC ACID(6705-34-6)
• EPA Substance Registry System: 2-PYRAZINEPROPANOIC ACID(6705-34-6)

Safety Data

• Hazardous Substances Data: 6705-34-6(Hazardous Substances Data)

Usage

General Description

2-Pyrazinepropanoic acid is a compound that is primarily used as a flavor ingredient in food and beverages. It has a molecular formula of C7H7N3O2 and a molecular weight of 169.15 g/mol. The chemical is a white to off-white crystalline powder that is soluble in water, and it has a characteristic odor. It is often utilized as a flavor enhancer in various food products, particularly in savory and meaty flavored foods. Additionally, it can also be used as a pharmaceutical intermediate in the production of certain drugs. Overall, 2-pyrazinepropanoic acid is an important chemical in the food and pharmaceutical industries due to its flavoring and pharmaceutical properties.

InChI:InChI=1/C7H8N2O2/c10-7(11)2-1-6-5-8-3-4-9-6/h3-5H,1-2H2,(H,10,11)

Upstream product

• 165530-42-7 tert-butyl 3-(pyrazin-2-yl)propanoate 

Downstream Products

• 5321-59-5 2-(2-pyrazinyl)ethanamine 

Relevant articles and documents

Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof

γ-Hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamide compounds are inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. These compounds are effective against HIV viral mutants which are resistant to HIV protease inhibitors currently used for treating AIDS and HIV infection.

Monoquaternized pyrazinium compounds and their use as electron carriers in photosynthetic processes

Substituted pyrazinium compounds having at least one polar group such as hydroxyl, carboxyl, carbamido or sulfonoxy can act as high energy electron carriers in photosynthetic processes such as those employing chlorophyll and a reduction enzyme. Such processes with the pyrazinium compounds can produce ammonia and hydrogen.